Profile
HCS Capital is a venture capital firm based in Miami, with additional offices in Santiago and Tel Aviv. Founded by a team with expertise in technology, banking, insurance, operations, and cybersecurity, they focus on partnering with individuals and corporations to invest in technology-driven companies. The team comprises various experienced partners and advisors that help portfolio companies implement sophisticated IT strategies and scale internationally.
HCS Capital invests primarily in technology sectors, supporting companies focusing on innovative solutions in Latam, North America, and Israel. They provide growth capital across various stages from venture to growth equity. Notably, they manage funds including HCS Tech Fund I and III, as well as a Corporate Venture Capital Fund. They leverage their extensive network to provide strategic guidance and access to global markets.
Some of HCS Capital's notable investments include companies across diverse sectors, focusing on disruptive and scalable technology solutions. Their involvement often includes helping these companies refine their strategies, improve operations, and effectively penetrate new markets.
Industry
HCS Capital Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
HCS Tech Fund I
|
Venture Capital (VC)
|
LegalTech
Cybersecurity
Energy
Infrastructure
Life Sciences
Technology
MedTech
Software
Security
Pharmaceuticals
Other
Medical Devices
Internet and Web Services
Industrial
Healthcare Services
Fintech
Financial Services
Digital
Business Services (B2B)
HealthTech
InsurTech
|
Seed
Series A
Late Stage (Series C+)
|
North America
Asia
|
$1-5 m
|
—
|
September 2026
|
|
Corporate Venture Fund II
|
Venture Capital (VC)
|
LegalTech
Cybersecurity
Energy
Infrastructure
Life Sciences
Technology
MedTech
Software
Security
Pharmaceuticals
Other
Medical Devices
Internet and Web Services
Industrial
Healthcare Services
Fintech
Financial Services
Digital
Business Services (B2B)
HealthTech
InsurTech
|
Seed
Series A
Late Stage (Series C+)
|
North America
Asia
|
$1-5 m
|
—
|
September 2026
|
|
HCS Tech Fund III
|
Venture Capital (VC)
|
LegalTech
Cybersecurity
Energy
Infrastructure
Life Sciences
Technology
MedTech
Software
Security
Pharmaceuticals
Other
Medical Devices
Internet and Web Services
Industrial
Healthcare Services
Fintech
Financial Services
Digital
Business Services (B2B)
HealthTech
InsurTech
|
Seed
Series A
Late Stage (Series C+)
|
North America
Asia
|
$1-5 m
|
—
|
September 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.